Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-137.21%
operating margin TTM
-98.57%
revenue TTM
17.15 Million
revenue per share TTM
0.12$
valuation ratios | |
|---|---|
| pe ratio | -0.49 |
| peg ratio | -0.01 |
| price to book ratio | 3.23 |
| price to sales ratio | 19.78 |
| enterprise value multiple | -14.95 |
| price fair value | 3.23 |
profitability ratios | |
|---|---|
| gross profit margin | 9.3% |
| operating profit margin | -98.57% |
| pretax profit margin | -137.21% |
| net profit margin | -137.21% |
| return on assets | -194.25% |
| return on equity | -361.83% |
| return on capital employed | -433.6% |
liquidity ratio | |
|---|---|
| current ratio | 0.88 |
| quick ratio | 0.83 |
| cash ratio | 0.24 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 9.49 |
| operating cycle | 18.21 |
| days of payables outstanding | 67.00 |
| cash conversion cycle | -48.79 |
| receivables turnover | 41.86 |
| payables turnover | 5.45 |
| inventory turnover | 38.47 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.14 |
| debt equity ratio | 0.48 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.32 |
| interest coverage | -167.24 |
| cash flow to debt ratio | -10.93 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.06 |
| cash per share | 0.01 |
| operating cash flow per share | -0.06 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -10.93 |
| short term coverage ratios | -14.86 |
| capital expenditure coverage ratio | -751.34 |
Frequently Asked Questions
When was the last time Genetic Technologies Limited (NASDAQ:GENE) reported earnings?
Genetic Technologies Limited (GENE) published its most recent earnings results on 30-09-2024.
What is Genetic Technologies Limited's current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Genetic Technologies Limited (NASDAQ:GENE)'s trailing twelve months ROE is -361.83%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Genetic Technologies Limited (GENE) currently has a ROA of -194.25%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did GENE's net profit margin stand at?
GENE reported a profit margin of -137.21% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is GENE's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 0.88 in the most recent quarter. The quick ratio stood at 0.83, with a Debt/Eq ratio of 0.48.